Comment on: Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' by Giollo et al

Clin Exp Rheumatol. 2023 Sep;41 Suppl 135(9):3. doi: 10.55563/clinexprheumatol/7ikqxf. Epub 2021 May 28.

Authors

Duriad Reffat¹, Magdalena Dziedzic², Ann O' Riordan¹, Fahd Adeeb³

Affiliations

¹ Department of Rheumatology, University Hospital Kerry, Ireland.
² Department of Radiology, University Hospital Kerry, Ireland.
³ Department of Rheumatology, University Hospital Kerry, Ireland. fahd_adeeb@yahoo.com.

PMID: 34128793
DOI: 10.55563/clinexprheumatol/7ikqxf

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / diagnosis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
Antibodies, Antineutrophil Cytoplasmic
COVID-19 Testing
COVID-19*
Humans
Pandemics

Substances

Antibodies, Antineutrophil Cytoplasmic